Latest Compugen Ltd (CGEN) Headlines Compugen's
Post# of 64
Posted On: 03/12/2014 7:15:32 PM
Latest Compugen Ltd (CGEN) Headlines
Compugen's Microsoft Licensing Solutions Expertise Reaffirmed
Marketwire - Tue Mar 11, 10:01AM CDT
Compugen Inc. is pleased to announce that as part of Microsoft Canada's comprehensive assessment of its partners' capabilities, Compugen will continue to retain the Licensing Solutions Partner (LSP) Authorization for Canada.
Uptrend Call Working As Compugen Stock Rises 19.7% (CGEN)
Comtex SmarTrend(R) - Thu Mar 06, 9:24AM CST
SmarTrend identified an Uptrend for Compugen (NASDAQ:CGEN) on January 7th, 2014 at $9.94. In approximately 2 months, Compugen has returned 19.72% as of today's recent price of $11.90.
Compugen concludes public offering of 6.9m ordinary shares
M2 - Thu Mar 06, 5:21AM CST
Drug company Compugen (NASDAQ:CGEN) (Tel Aviv:CGEN.TA), based in Israel, revealed on Wednesday the completion of its public offering of 6.9m ordinary shares at a price of USD10.50 per share.
Compugen Ltd. Closes Public Offering of Ordinary Shares
Business Wire - Wed Mar 05, 3:05PM CST
Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) today announced that it has closed its underwritten public offering of 6,900,000 ordinary shares, including 900,000 shares sold pursuant to the full exercise of the underwriters' option to purchase additional shares, at a price to the public of $10.50 per share. Gross proceeds to Compugen are approximately $72.5 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Compugen.
Compugen prices public offering of ordinary shares at USD10.50 per share
M2 - Mon Mar 03, 4:16AM CST
Drug company Compugen (NASDAQ:CGEN) (Tel Aviv:CGEN.TA) said on Friday that it has priced a public offering of 6,000,000 ordinary shares at USD10.50 per share.
Nasdaq stocks posting largest volume increases
AP - Fri Feb 28, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage decreases
AP - Fri Feb 28, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
Why Compugen Ltd. Shares Got Hammered
Sean Williams, The Motley Fool - Motley Fool - Fri Feb 28, 12:44PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Compugen , a biopharmaceutical company...
Compugen Ltd. Prices Public Offering of Ordinary Shares
Business Wire - Fri Feb 28, 8:15AM CST
Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) today announced that it has priced an underwritten public offering of 6,000,000 ordinary shares at a price to the public of $10.50 per share. Gross proceeds to Compugen are expected to be $63 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Compugen. The offering is expected to close on or about March 5, 2014, subject to satisfaction of customary closing conditions. Compugen has granted the underwriters a thirty (30) day option to purchase up to 900,000 additional ordinary shares.
Compugen plans to issue ordinary shares in public offering
M2 - Fri Feb 28, 3:05AM CST
Drug company Compugen (NASDAQ:CGEN) (Tel Aviv:CGEN.TA) reported on Thursday the start of an underwritten public offering of its ordinary shares.
Compugen Ltd. Announces Proposed Public Offering of Ordinary Shares
Business Wire - Thu Feb 27, 3:17PM CST
Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) today announced that it has commenced an underwritten public offering of its ordinary shares. All of the ordinary shares in the offering are being offered by Compugen. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Compugen Shares Up 34.6% Since SmarTrend's Buy Recommendation (CGEN)
Comtex SmarTrend(R) - Wed Feb 26, 9:45AM CST
SmarTrend identified an Uptrend for Compugen (NASDAQ:CGEN) on January 7th, 2014 at $9.94. In approximately 2 months, Compugen has returned 34.61% as of today's recent price of $13.38.
'Mad Money' Lightning Round: I Like Vodafone
at The Street - Wed Feb 26, 5:00AM CST
Cramer also likes Verizon and Palo Alto Networks but says Tupperware's last quarter wasn't up to par.
Political Party Calls for Finance Reform
by Darren Taylor - All Africa Global Media - Wed Feb 26, 3:40AM CST
Tellinger is a singer, an actor and the author of several books on the origins of humankind and ancient civilizations.
MENA Renewable Energy Report 2013
M2 - Wed Feb 26, 3:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/ztshkv/mena_renewable) has announced the addition of the "MENA Renewable Energy Report 2013" report to their offering. A Comprehensive Review Of Trends And Prospects In The Renewable Energy Sector Across The Middle East And North Africa Region The Middle East this year enters a new era in which renewable energy will play a strategic role in delivering electric power to agriculture, industry and urban areas. Total renewable energy capacity will grow to more than 30,000MW by end of 2020 and total expected investment in non-hydroelectric power stations required to deliver the additional capacity will be $115bn. Egypt will be the largest MENA non-hydroelectric renewable energy generation market followed by Morocco, Saudi Arabia and the UAE. The report assesses the renewable energy sector in 14 MENA countries. The report provides details of major developments in the GCC and focuses on renewable energy programme in Saudi Arabia. The challenges and opportunities are analysed along with the history, policies, targets, projects and key clients. Comprising more than 100 pages, the MENA Renewable Energy 2013 report provides a detailed analysis of the existing renewable energy sector across the region along with a comprehensive forecast for demand growth, additional capacity and investment requirements. Through this comprehensive report you will gain exclusive insight into: - Data on existing renewable energy capacity and planned projects - Renewable energy programme in Saudi Arabia - Regulations, policies and capacity of finance systems - Top clients and contractor rankings - Key opportunities, challenges and much more... Save time and investment on research and analysis. Gather exclusive data on the MENA Renewable energy market through this in-depth examination. For more information visit http://www.researchandmarkets.com/research/zt..._renewable About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Jim Cramer's 'Mad Money' Recap: An Irrational Market
at The Street - Tue Feb 25, 7:06PM CST
Cramer likes the market but is concerned with what he's seeing with the action on Netflix, LinkedIn and Tesla
Compugen to Present Cancer Immunotherapy Programs at Three International Cancer Conferences in March
Business Wire - Thu Feb 20, 6:00AM CST
Compugen Ltd. (NASDAQ: CGEN) today announced that its scientists are presenting at three international cancer conferences next month:
Compugen's Microsoft Licensing Solutions Expertise Reaffirmed
Marketwire - Tue Mar 11, 10:01AM CDT
Compugen Inc. is pleased to announce that as part of Microsoft Canada's comprehensive assessment of its partners' capabilities, Compugen will continue to retain the Licensing Solutions Partner (LSP) Authorization for Canada.
Uptrend Call Working As Compugen Stock Rises 19.7% (CGEN)
Comtex SmarTrend(R) - Thu Mar 06, 9:24AM CST
SmarTrend identified an Uptrend for Compugen (NASDAQ:CGEN) on January 7th, 2014 at $9.94. In approximately 2 months, Compugen has returned 19.72% as of today's recent price of $11.90.
Compugen concludes public offering of 6.9m ordinary shares
M2 - Thu Mar 06, 5:21AM CST
Drug company Compugen (NASDAQ:CGEN) (Tel Aviv:CGEN.TA), based in Israel, revealed on Wednesday the completion of its public offering of 6.9m ordinary shares at a price of USD10.50 per share.
Compugen Ltd. Closes Public Offering of Ordinary Shares
Business Wire - Wed Mar 05, 3:05PM CST
Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) today announced that it has closed its underwritten public offering of 6,900,000 ordinary shares, including 900,000 shares sold pursuant to the full exercise of the underwriters' option to purchase additional shares, at a price to the public of $10.50 per share. Gross proceeds to Compugen are approximately $72.5 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Compugen.
Compugen prices public offering of ordinary shares at USD10.50 per share
M2 - Mon Mar 03, 4:16AM CST
Drug company Compugen (NASDAQ:CGEN) (Tel Aviv:CGEN.TA) said on Friday that it has priced a public offering of 6,000,000 ordinary shares at USD10.50 per share.
Nasdaq stocks posting largest volume increases
AP - Fri Feb 28, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage decreases
AP - Fri Feb 28, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
Why Compugen Ltd. Shares Got Hammered
Sean Williams, The Motley Fool - Motley Fool - Fri Feb 28, 12:44PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Compugen , a biopharmaceutical company...
Compugen Ltd. Prices Public Offering of Ordinary Shares
Business Wire - Fri Feb 28, 8:15AM CST
Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) today announced that it has priced an underwritten public offering of 6,000,000 ordinary shares at a price to the public of $10.50 per share. Gross proceeds to Compugen are expected to be $63 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Compugen. The offering is expected to close on or about March 5, 2014, subject to satisfaction of customary closing conditions. Compugen has granted the underwriters a thirty (30) day option to purchase up to 900,000 additional ordinary shares.
Compugen plans to issue ordinary shares in public offering
M2 - Fri Feb 28, 3:05AM CST
Drug company Compugen (NASDAQ:CGEN) (Tel Aviv:CGEN.TA) reported on Thursday the start of an underwritten public offering of its ordinary shares.
Compugen Ltd. Announces Proposed Public Offering of Ordinary Shares
Business Wire - Thu Feb 27, 3:17PM CST
Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) today announced that it has commenced an underwritten public offering of its ordinary shares. All of the ordinary shares in the offering are being offered by Compugen. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Compugen Shares Up 34.6% Since SmarTrend's Buy Recommendation (CGEN)
Comtex SmarTrend(R) - Wed Feb 26, 9:45AM CST
SmarTrend identified an Uptrend for Compugen (NASDAQ:CGEN) on January 7th, 2014 at $9.94. In approximately 2 months, Compugen has returned 34.61% as of today's recent price of $13.38.
'Mad Money' Lightning Round: I Like Vodafone
at The Street - Wed Feb 26, 5:00AM CST
Cramer also likes Verizon and Palo Alto Networks but says Tupperware's last quarter wasn't up to par.
Political Party Calls for Finance Reform
by Darren Taylor - All Africa Global Media - Wed Feb 26, 3:40AM CST
Tellinger is a singer, an actor and the author of several books on the origins of humankind and ancient civilizations.
MENA Renewable Energy Report 2013
M2 - Wed Feb 26, 3:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/ztshkv/mena_renewable) has announced the addition of the "MENA Renewable Energy Report 2013" report to their offering. A Comprehensive Review Of Trends And Prospects In The Renewable Energy Sector Across The Middle East And North Africa Region The Middle East this year enters a new era in which renewable energy will play a strategic role in delivering electric power to agriculture, industry and urban areas. Total renewable energy capacity will grow to more than 30,000MW by end of 2020 and total expected investment in non-hydroelectric power stations required to deliver the additional capacity will be $115bn. Egypt will be the largest MENA non-hydroelectric renewable energy generation market followed by Morocco, Saudi Arabia and the UAE. The report assesses the renewable energy sector in 14 MENA countries. The report provides details of major developments in the GCC and focuses on renewable energy programme in Saudi Arabia. The challenges and opportunities are analysed along with the history, policies, targets, projects and key clients. Comprising more than 100 pages, the MENA Renewable Energy 2013 report provides a detailed analysis of the existing renewable energy sector across the region along with a comprehensive forecast for demand growth, additional capacity and investment requirements. Through this comprehensive report you will gain exclusive insight into: - Data on existing renewable energy capacity and planned projects - Renewable energy programme in Saudi Arabia - Regulations, policies and capacity of finance systems - Top clients and contractor rankings - Key opportunities, challenges and much more... Save time and investment on research and analysis. Gather exclusive data on the MENA Renewable energy market through this in-depth examination. For more information visit http://www.researchandmarkets.com/research/zt..._renewable About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Jim Cramer's 'Mad Money' Recap: An Irrational Market
at The Street - Tue Feb 25, 7:06PM CST
Cramer likes the market but is concerned with what he's seeing with the action on Netflix, LinkedIn and Tesla
Compugen to Present Cancer Immunotherapy Programs at Three International Cancer Conferences in March
Business Wire - Thu Feb 20, 6:00AM CST
Compugen Ltd. (NASDAQ: CGEN) today announced that its scientists are presenting at three international cancer conferences next month:
(0)
(0)Compugen Ltd. (CGEN) Stock Research Links
Scroll down for more posts ▼